Clinical Trials Browser

Active not recruiting × Small Cell Lung Carcinoma × veliparib × Clear all

NCT01638546 2026-04-29

Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

Phase 2 Active not recruiting

97 enrolled 12 charts

Small Cell Lung Carcinoma